Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysisLiu, Dan ; Li, Xiaodan ; Zhang, Yonggang ; Kwong, Joey Sum-Wing ; Li, Ling ; Zhang, Yiyi ; Xu, Chang ; Li, Qianrui ; Sun, Xin ; Tian, Haoming ; Li, SheyuDrug design, development and therapy, 2018-01, Vol.12, p.1685-1695 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
2 |
Material Type: Artigo
|
Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trialsLi, Xiaofei ; Wan, Jia ; Wu, Zhenping ; Tu, Juncai ; Hu, Yongtao ; Wu, Shuang ; Lou, LianqingDrug design, development and therapy, 2018-01, Vol.12, p.3043-3049 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
3 |
Material Type: Artigo
|
The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patientsFan, Zhong-Guo ; Ding, Guo-Bin ; Li, Xiao-Bo ; Gao, Xiao-Fei ; Gao, Ya-Li ; Tian, Nai-LiangDrug design, development and therapy, 2016-01, Vol.10, p.3435-3448 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
4 |
Material Type: Artigo
|
Vitamin D deficiency and the risk of tuberculosis: a meta-analysisHuang, Shao-Jun ; Wang, Xian-Hua ; Liu, Zhi-Dong ; Cao, Wen-Li ; Han, Yi ; Ma, Ai-Guo ; Xu, Shao-FaDrug design, development and therapy, 2017-01, Vol.11, p.91-102 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
5 |
Material Type: Artigo
|
Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trialsZhou, Jian Xin ; Feng, Li Jin ; Zhang, XiDrug design, development and therapy, 2017-01, Vol.11, p.3009-3017 [Periódico revisado por pares]New Zealand: Taylor & Francis LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Subarachnoid and epidural dexmedetomidine for the prevention of post-anesthetic shivering: a meta-analysis and systematic reviewLi, Yi-Zheng ; Jiang, Yi ; Lin, Han ; Yang, Xue-PingDrug design, development and therapy, 2019-11, Vol.13, p.3785-3798 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
7 |
Material Type: Artigo
|
Safety and efficacy of durvalumab (MEDI4736) in various solid tumorsYang, Hui ; Shen, Kai ; Zhu, Chenjing ; Li, Qingfang ; Zhao, Yunuo ; Ma, XueleiDrug design, development and therapy, 2018-01, Vol.12, p.2085-2096 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
8 |
Material Type: Artigo
|
Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysisWang, Yuan ; Hu, Guo-Fang ; Zhang, Qian-Qian ; Tang, Ning ; Guo, Jun ; Liu, Li-Yan ; Han, Xiao ; Wang, Xia ; Wang, Zhe-HaiDrug design, development and therapy, 2016-01, Vol.10 (Issue 1), p.1961-1972 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
9 |
Material Type: Artigo
|
Doublet vs Single-Agent Maintenance Therapy in the Treatment of Non-Small-Cell Lung Cancer: A Meta-AnalysisQi, Jing ; Guo, Xiuzhi ; Li, AihuaDrug design, development and therapy, 2020-01, Vol.14, p.2179-2185 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
|
10 |
Material Type: Artigo
|
Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysisZhong, Ping ; Wu, Danhong ; Ye, Xiaofei ; Wu, Ying ; Li, Tuming ; Tong, Shuwen ; Liu, XueyuanDrug design, development and therapy, 2017-01, Vol.11, p.2517-2526 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |